Cargando…
Correction: Evaluation of the safety of live attenuated influenza vaccine (LAIV) in children and adolescents with asthma and high-risk conditions: a population-based prospective cohort study conducted in England with the Clinical Practice Research Datalink
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398688/ https://www.ncbi.nlm.nih.gov/pubmed/30819718 http://dx.doi.org/10.1136/bmjopen-2018-023118corr1 |
Ejemplares similares
-
Evaluation of the safety of live attenuated influenza vaccine (LAIV) in children and adolescents with asthma and high-risk conditions: a population-based prospective cohort study conducted in England with the Clinical Practice Research Datalink
por: Caspard, Herve, et al.
Publicado: (2018) -
Safety of live attenuated influenza vaccine (LAIV) in children with moderate to severe asthma
por: Turner, Paul J., et al.
Publicado: (2020) -
Impact of Pre-Existing Immunity to Influenza on Live-Attenuated Influenza Vaccine (LAIV) Immunogenicity
por: Roy, Sreeja, et al.
Publicado: (2020) -
Epidemiological Impact of the Pediatric Live Attenuated Influenza Vaccine (LAIV) Program on Group A Streptococcus (GAS) Infection in England
por: Sinnathamby, Mary A, et al.
Publicado: (2023) -
985. Safety of Guidelines Recommending LAIV for Routine Use in Children and Adolescents With Asthma
por: Nordin, James, et al.
Publicado: (2018)